Related by context. Frequent words. (Click for all words.) 70 Initiates Phase 67 Panzem R 67 Completes Enrollment 66 anticancer compound 65 sodium Injection 65 Presents Positive 63 phase IIb clinical 63 Pivotal Phase 63 humanized anti 63 Pivotal Phase III 62 humanized monoclonal antibody 62 Phase III Clinical Trial 62 Phase 2b clinical trials 62 liposomal formulation 62 RGB # 62 thymalfasin 62 L Annamycin 61 Committed Equity 61 Phase IIb trials 61 MKC# 61 Clinical Trial Results 61 MEK inhibitor 61 DNA RNA Medicines 61 Pharmion Corporation 61 Genasense R oblimersen 61 Tesetaxel 61 Cetrorelix 61 Ofatumumab 61 HCV protease inhibitor 60 PEG SN# 60 Genaera Corporation 60 placebo controlled Phase 60 Inc Therapeutic Competitors 60 Epratuzumab 60 forodesine 60 HGS ETR1 60 Visit www.qsii.com 60 Report companiesandmarkets.com adds 60 CK # novel 60 Harbor BioSciences 60 Traficet EN 60 Phase IIa clinical trials 60 Phase 2a clinical 60 relapsed refractory multiple myeloma 60 Shigamabs ® 60 non nucleoside polymerase 60 Metastatic Melanoma 60 SAR# [004] 60 Phase 2a 60 MGCD# [001] 60 Phase 2a trial 60 Patient Enrollment 60 RiVax ™ 60 orally bioavailable 60 Perifosine 60 orally absorbed 60 metastatic hormone refractory 59 nicotinic alpha 7 59 Bortezomib 59 pulmonology portfolio 59 Aurora kinase 59 RegeneRx Biopharmaceuticals Inc. 59 multi kinase inhibitor 59 Idera Pharmaceuticals 59 Phase IIB 59 multicenter Phase 59 antisense drug 59 businesses visit www.penton.com 59 Nasdaq VRTX 59 talactoferrin 59 CYC# 59 OncoVEX GM CSF 59 Metabasis Therapeutics Inc. 59 Drug Candidate 59 IMC A# 59 novel orally administered 59 ANYARA 58 elotuzumab 58 confirmatory Phase 3 58 MNTX 58 epothilone 58 Gemzar ® 58 rNAPc2 58 Phase 2b clinical 58 MPS IVA 58 phase IIb 58 FDA Accepts 58 Inc. Nasdaq IMGN 58 CR# vcMMAE 58 phase IIa 58 ISTODAX 58 Phase 2b study 58 Phase 1b 58 FermaVir 58 Phase Ib clinical 58 investigational oral 58 IIa trial 58 Bicifadine 58 R sorafenib tablets 58 Phase Ib 58 Advancing Drugs